Company intelligence
Boyds
Over 20 years supporting the global development of cutting-edge medicines for the benefit of patients.
About Boyds
At Boyds, our goal is to facilitate the translation of cutting-edge science into medicinal products which benefit patients. We understand how challenging this can be, both technically and commercially. Our service is designed to provide crucial experience and assistance whenever you need it, in order to bring your innovations to the marketplace as quickly and efficiently as possible. Boyds was established in 2005 and provides a range of expertise and skills central to the development of pharmaceutical and biotechnology medicinal products and medical devices. We are headquartered in the UK with offices located in Cheshire and Cambridgeshire and also have offices in Dublin and Pennsylvania. Our consultancy services offer a cost-effective solution for those requiring expert assistance in order to expedite development, add value to their product, and reach those key milestones. Whether it relates to a single issue or a long-term commitment to your development team, we can help you chart the innovative course great science demands.
Verified activity
Signals from Boyds
2 published signals
Research & Knowledge
Boyds published the September edition of its Regulatory Intelligence Digest, which includes updates from the FDA, EMA, MHRA, and ICH.
Reported by Boyds
Presence & Recognition
Boyds announced that Professor Alan Boyd MBE FMedSci will speak at the Faculty of Pharmaceutical Medicine’s Annual Conference on Tuesday 24 November 2026 in the Debate Session on Is the Current Pharma Model Sustainable.
Reported by Boyds